Kraig Biocraft Laboratories Inc. has announced that it has completed production and genetic screening of its latest batch of spider silk silkworm eggs. These specialized silkworm eggs are now ready for shipment to Vietnam to restart commercial production.
Production operations at the company’s factory were suspended in March due to a mandatory shutdown, resulting from the global spread of COVID-19. During the COVID-19 quarantine, Kraig Labs’ U.S.-based team focused its efforts on improving the performance and genetics of its Dragon Silk strain of recombinant spider silk silkworms. The company’s U.S. operations also used this time to scale up its supply of silkworm eggs to allow for a restart of its operations in Vietnam.
Kraig Biocraft Laboratories Inc., a reporting biotechnology company, is a developer of genetically engineered spider silk-based fiber technologies.